Congratulations to Our Digital RESI June Innovation Challenge Winners!

11 Jun

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claire

Our 3-day Digital RESI June conference came to an end yesterday, and we are very excited to announce the Top 3 Winners of the Innovation Challenge. Each participating finalist company had a dedicated page where you could view their virtual poster, short pitch, and other supplementary materials that the companies made available for viewing.

We will keep our Digital RESI June “live agenda” page open to the public for another month, so if you have not had the chance already, please visit Digital RESI June Live Agenda to see our virtual exhibit of some amazing technologies across therapeutics, medical devices, diagnostics, and digital health!

We would like to thank every Innovation Challenge company for their virtual presentations, and the hard work they put in to promote their technologies to RESI attendees. In all, we hope that all companies were able to make the most out of the digitally presented Innovation Challenge.

The Top 3 winners will be awarded with free tickets to future RESI conferences. Congratulations to the Top 3 winners, and thank you all for casting your votes!

First Place: Sen-Jam Pharmaceutical

Click Here to Check Out Sen-Jam Pharmaceutical’s Digital Poster

Sen-Jam Pharmaceutical is a therapeutics company focused on rapidly developing drugs to reduce pain and inflammation. We do this by combining approved FDA drugs that have never been combined before to create new formulations. Our 3 lead drugs are at varying stages of development for treatments including Viral Respiratory Infections (e.g. COVID-19), Opioid Withdrawal, and Alcohol Hangover prevention. We have 24+ Patents awarded and pending.

Jacqueline Iversen, RPh, MS, Head of Clinical Development, Sen-Jam Pharmaceutical | Jim Iversen, CEO/COO, Sen-Jam Pharmaceutical

Second Place: AyuVis Research

Click Here to Check Out AyuVis Research’s Digital Poster

AyuVis Research, Inc. is a late preclinical stage pharmaceutical company with novel small molecule compounds for treating complicated respiratory diseases like bronchopulmonary dysplasia (BPD), bacterial pneumonia, acute respiratory distress syndrome (ARDS) and systemic inflammatory syndrome (sepsis). A pre-IND meeting with the FDA is completed. The compounds modulate the innate immune system to control hyperinflammation and eliminate microbial pathogens. AyuVis’ new class of drug can also prevent and treat conditions like severe COVID-19 infection related lung injuries, ARDS, multiple organ failure and death, where traditional protocols have had limited results. Preclinical testing in animal models have demonstrated effective results for intravenous (IV), intranasal (IN), and intraperitoneal (IP) administration of the drug depending on the target disease and tissue being treated.

Suchismita Acharya, PhD, President and CEO & Management Team

Third Place: Oxidien Pharmaceuticals

Click Here to Check Out Oxidien Pharmaceuticals’ Digital Poster

Oxidien Pharmaceuticals is a clinical stage drug development company developing a treatment for enteric hyperoxaluria, a large unmet need in kidney disease. We have excellent safety and efficacy data using our proprietary, oral biologic with significant advantages over products in development. Enteric hyperoxaluria is a condition that affects 250,000 patients in the US alone. The company spun out from Captozyme, Inc., in 2019, before Captozyme was acquired by Arranta Bio in November of 2019. Oxidien is now presenting a de-risked opportunity for an investment partner to come in early as we get ready for a dose-finding Phase 2 study.

Helena Cowley, CEO, Oxidien Pharmaceuticals

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: